It appears that Neuralstem ( ) may very well open a trial for chronic injuries this summer if everything goes well at the FDA. The trial would be very similar to what they did with ALS last year so the hurdle isn't as high as for an unproven cell intervention. They have no information about it on their website yet. I will post when more information becomes publicly available (good or bad about FDA approval)